Search Results 1421-1430 of 42852 for oral

1. A Blanket Protocol To Study Oral Regorafenib In Patients With Selected Sarcoma Subtypes - Mayo Clinic

   Regorafenib might or might not slow down the growth of your tumor, or shrink your tumor. Regorafenib is approved in the United States to treat colon cancer and ...

2. Fosfomycin (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (powder for solution):. For treatment of bladder infection: Adults—3 grams (one packet) dissolved in water taken one time. Teenagers 13 ...

3. Canagliflozin and metformin (oral route) - Side effects & dosage - Mayo Clinic

   For type 2 diabetes: For oral dosage form (extended-release tablets):. For patients not on canagliflozin or metformin treatment: Adults and children 10 years ...

4. Jonathan Fillmore, M.D., D.M.D. - Mayo Clinic Faculty Profiles

   ... oral and facial surgeries. ... PROFESSIONAL DETAILS. Primary Appointment. Consultant, Division of Oral Diagnosis and Oral and Maxillofacial Surgery, Department of ...

5. Monday's Housecall - Mayo Clinic News Network

   Taking care of your oral health is an investment in your overall health. Here's why. Expert Answers When to brush your teeth · Illustration of organic food ...

6. Calcium oxybate, magnesium oxybate, potassium oxybate, and sodium oxybate (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (solution):. For cataplexy or excessive daytime sleepiness: Adults—At first, 2.25 grams (g) taken at bedtime (first dose), then ...

7. Vanzacaftor, tezacaftor, and deutivacaftor (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For cystic fibrosis: Adults and children 12 years of age and older—2 tablets (containing vanzacaftor 10 milligrams (mg) ...

8. Chlorpheniramine, ibuprofen, and pseudoephedrine (oral route) - Side effects & dosage - Mayo Clinic

   For oral dosage form (tablets):. For symptoms of allergies and cold: Adults and children 12 years of age and older—1 tablet every 4 to 6 hours a day. Do not ...

9. A Study Of Budesonide Oral Suspension With Subcutaneous Dupilumab On Esophageal Diameter And Fibrotic Change In EOE - Mayo Clinic

   Clinical Trials · A Study Of Budesonide Oral Suspension With Subcutaneous Dupilumab On Esophageal Diameter And Fibrotic Change In EOE · More about research at ...

10. Daily Oral Regorafenib For Chemotherapy-Refractory, Metastatic And Locally Advanced Angiosarcoma - Mayo Clinic

    Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...